ArticleMolecular oncology2019

Targeting HER2 in patient-derived xenograft ovarian cancer models sensitizes tumors to chemotherapy.

Faye R Harris et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.